Multiple sclerosis Innate immune system Biobank Area postrema syndrome Animal model Biomarkers Children NMOSD Cancer immunotherapy Neurite outgrowth Longitudinally extensive transverse myelitis Ependymal cell neuromyelitis optica aquaporin-4 cilia sub-ventricular zone Bright Immune checkpoint inhibitors Reproductive assistance GABA Ependymal cell Myelin oligodendrocyte glycoprotein Jaundice Neuraxial analgesia Influx constant Cytokines Neural antibodies Drosophila Cannabinoid receptor type 2 Endocannabinoid system Microglia Neuroinflammation ERRα Rituximab Microenvironment Central nervous system Breastfeeding Cilia Aquaporin-4 antibody Neurological immune-related adverse events Aquaporin-4-IgG AQP4-IgG Cancer Bone Optic neuritis Registry Estradiol Adult neurogenesis Neuroinflammation CP Neuroscience Gunn Adverse events Connexins Collapsing response mediator protein Demyelination Relapses CD14 Anti-GFAP encephalomyelitis CRMP5 Post-partum Immunosuppressant Disease-modifying treatments MRI MOG Microglia Blood-brain barriers Database Circadian clock Aquaporin-4 antibodies Treatment response Pregnancy Glutamate Aquaporin-4 Myelitis Cannabinoid receptor type 2 Autoimmune diseases Meninges Disease modifying treatments MOGAD Autoantibodies Amino acid Blood–brain barrier GSK-3β Blood-brain barrier Claudin MOG antibodies Embryo Hippocampus CP Molecular biology Glia COVID-19 Clinically isolated syndrome CIS Multiple sclerosis MS Neuromyelitis optica Choroid plexus Blood brain barrier Lateral diffusion Cerebrospinal fluid Astrocyte MOG-IgG associated disorders MOGAD Encephalitis Blood–CSF barrier Toll-like receptor Prognosis LAT1 B cells Endocannabinoid system Autoimmune encephalitis